What are the Challenges to the Diagnosis of Respiratory Tract Infections (RTIs)?
Upper respiratory tract infections are the most common diseases globally. In 2019 alone, there were 17.2 billion episodes globally, equating to more than 2.25 episodes per person annually, and up to 3 episodes per year in children. These infections impose a considerable socio-economic burden, being a leading reason for general practitioner visits and a primary cause of sick leave.¹ Lower respiratory diseases account for 2.377 million deaths worldwide each year. In industrialized nations, respiratory infections are the main reason for pediatric consultations and play a significant role in healthcare-associated infections and epidemics.² Lower respiratory tract infections remain the top cause of death from infectious diseases.²
While both upper and lower RTIs are extremely common, their diagnosis remains challenging for clinicians due to their diverse clinical presentations, varying severities, and the wide range of causative microorganisms, including bacteria, viruses, fungi, and parasites. Timely and precise diagnosis is essential for selecting the most appropriate treatment.
Respiratory Co-Infection Video
COVID-19 Respiratory Co-Infections
Respiratory Tract Infections - Our Diagnostic Offer
As a leader in infectious disease diagnostics, you can count on bioMérieux to deliver the products you need to support RTI diagnostics from sample collection to guided therapy to antibiotic discontinuation. Our respiratory tract infection offer is reinforced by our promise to be a committed service partner for all our products from consultancy to installation, connectivity, training, verification, and customer service to help our customers achieve optimized time to therapy for better patient care and to fight antimicrobial resistance.
Disclaimer: Product availability varies by country. Please consult your local bioMérieux representative for product availability in your country.
-
BIOFIRE® FILMARRAY® TORCH
Easier testing. Faster results.
Syndromic infectious disease testing with BIOFIRE® FILMARRAY® TORCH is the fastest way to better results.
-
BIOFIRE® Respiratory 2.1 and 2.1plus Panels
1 Test. Up to 23 Targets. ~45 Minutes.
The BIOFIRE RP2.1 and RP2.1plus Panels use the syndromic approach to accurately detect and identify the pathogens most associated with respiratory infections. Fast and comprehensive results may enable better-informed diagnosis and treatment of patients.
-
BIOFIRE® FILMARRAY® Pneumonia & Pneumonia plus Panels
1 Test. Up to 34 Targets. ~1 Hour.
Syndromic tests targeting a comprehensive menu of bacteria and viruses that cause pneumonia and other lower respiratory tract infections, as well as 7 genetic markers of antibiotic resistance.
-
SARS-COV-2 FLUA/FLUB/RSV R-GENE®
Real-time PCR detection kit
Detect & differentiate SARS-CoV-2, Influenza A, Influenza B and RSV in 1 PCR test.
-
BIOFIRE® SPOTFIRE® System
This Changes Everything.
The BIOFIRE® SPOTFIRE® System is the latest advancement in molecular infectious disease diagnostics from bioMérieux for Point-of-Care testing, offering rapid and actionable results onsite.
-
BIOFIRE® SPOTFIRE® Respiratory/Sore Throat Panels
Comprehensive Onsite PCR Results in ~15 Minutes.
The BIOFIRE SPOTFIRE Respiratory/Sore Throat (R/ST) Panels enable testing for respiratory pathogens from either a nasopharyngeal swab, a throat swab or an anterior nasal swab, providing a flexible respiratory solution to meet the unique needs of point-of-care settings.
-
ETEST®
Antibiotic Susceptibility Testing Reagent Strips to Determine On-Scale MICs
Clinicians often need more information than what primary AST can provide. Recognized around the world for their proven performance, ETEST® ready to use reagent strips determine on-scale MICs.
-
VITEK® MS PRIME
New-Generation Mass Spectrometry Microbial Identification System
VITEK® MS PRIME combines microbiology expertise with innovation taking mass spectrometry to the next level by maximizing the impact of daily laboratory workflow for better patient care.
-
VITEK® 2
Fully integrated Identification and Antimicrobial Susceptibility Testing
VITEK® 2, the leading automated system for routine antimicrobial susceptibility testing, provides efficient workflow, faster AST results. Its fully-integrated ID & AST approach ensures superior performance to rapidly and confidently guide therapy.
-
VITEK® 2 ID & AST Cards
Rapid. Flexible. Efficient.
Providing accurate and reliable identification and antimicrobial susceptibility results for clinically relevant organisms with self-contained, disposable test cards designed for VITEK® 2 automated systems.
-
VIDAS® B•R•A•H•M•S PCT™
Important Biomarker for Improved Patient Management
Detects procalcitonin, a biomarker that aids in the risk assessment for progression to severe sepsis and septic shock. PCT also aids in decision making on antibiotic therapy for patients with lower respiratory tract infections (LRTI).
-
BIOFIRE® FIREWORKS™
Optimize Diagnostics With Data-driven Solutions.
Providing access to a centralized data management web portal to give users total insights and analytics into BIOFIRE® System performance, utilization, pathogen surveillance, workflow management, and more.
-
CLARION™
AUGMENTING THE VALUE OF DIAGNOSTIC DATA
Analytics for diagnostic stewardship, designed to transform microbiology and molecular data into actionable insights.
-
MAESTRIA™
New Generation Microbiology Middleware
An innovative, integrated software solution designed to orchestrate your lab routine and transform data into actionable insights.
-
VILINK®
Optimize Instrument UPTIME to Improve Laboratory Productivity
A secure solution offering remote access, proactive maintenance, and remote updates. VILINK® diagnoses, solves software and instrument issues, and supports your systems to enable laboratory productivity and efficiency improvements.
-
BIOMERIEUX LAB CONSULTANCY AND CHANGE MANAGEMENT SERVICES
Microbiology Expertise and Consultancy to Optimize Lab Performance
Transforming laboratories together to control costs, maximize quality, shorten time to result, and empower staff.
Useful Resources on Respiratory Tract Infections
%20Panel%20Information%20Sheet%20Thumbnail?qlt=85&ts=1761128529966&dpr=off)
%20Panel%20Information%20Sheet%20Thumbnail?qlt=85&ts=1761128575481&dpr=off)
Contact us
References
1. Jin X, Ren J, Li R, Gao Y, Zhang H, Li J, et al. Global burden of upper respiratory infections in 204 countries and territories, from 1990 to 2019. EClinicalMedicine. 2021;37:100986.
2. Collaborators GBDLRI. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet Infectious diseases. 2018;18(11):1191-210.